FDA's Biosimilar Rules Will Provide Testing Clarity
The U.S. Food and Drug Administration's biosimilars guidances provide some rules of the road for successfully navigating the highway to approval of a biosimilars application under Section 351. The FDA's newest...To view the full article, register now.
Already a subscriber? Click here to view full article